Analyst: Ambu's unsightly downgrade is tied to unmet growth expectations

The medtech firm’s Achilles’ heel is its Visualizations business, which might be scaling down in the future, assesses an analyst.
Photo: Ambu / PR
Photo: Ambu / PR
by marketwire, translated by daniel pedersen

Shareholders of Ambu must be a patient bunch. Again and again, the Danish medtech firm has downgraded its financial expectations – seven times under the previous leadership of the company, and on Wednesday, new Chief Executive Officer Britt Meelby Jensen announced the eighth financial revision.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading